Home›Companies›Biotech & Pharma›Relation Therapeutics

Relation Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 9, 2025·Suggest an edit

About Relation Therapeutics

Relation Therapeutics is a private company based in Miami Beach, Florida, incorporated in 2021 in Delaware. It has reported $116,426,846 raised in five offerings on Form D since August 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 21, 2025Dec 9, 2025$36,175,000fully sold5$7.2MDebt, Securities on exercise, Convertible Promissory NoteRule 506(b)Form D ↗
Nov 22, 2024Dec 10, 2024$15,000,000fully sold1$15.0MDebt, Securities on exercise, Convertible Promissory NoteRule 506(b)Form D ↗
Jan 9, 2024Jan 19, 2024$40,251,846of $51.6M target10$4.0MEquityRule 506(b)Form D ↗
May 19, 2022Jun 3, 2022$16,000,000fully sold8$2.0MDebt, Securities on exerciseRule 506(b)Form D ↗
Jul 28, 2021Aug 10, 2021$9,000,000fully sold10$900KEquityRule 506(b)Form D ↗
Total, five offerings$116,426,846

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Relation Therapeutics's Form D filed Dec 9, 2025.

DR
David Roblin
Executive officer and director
CR
JP
Jason Pontin
Director
Also a director at Kanvas Biosciences and Proxima.
JM
Jim Mellon
Director
CS
Casey Swerner
President

Sources

  1. SECRelation Therapeutics Inc. filing history